Translation, Eukaryotic translation initiation factor 3 subunit E
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 4 |
Pissara et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005852 | eukaryotic translation initiation factor 3 complex | 2 | 12 |
GO:0016282 | eukaryotic 43S preinitiation complex | 4 | 11 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0033290 | eukaryotic 48S preinitiation complex | 4 | 11 |
GO:0070993 | translation preinitiation complex | 3 | 11 |
GO:0071540 | eukaryotic translation initiation factor 3 complex, eIF3e | 3 | 11 |
GO:1990904 | ribonucleoprotein complex | 2 | 11 |
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I3W2
Term | Name | Level | Count |
---|---|---|---|
GO:0001732 | formation of cytoplasmic translation initiation complex | 7 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0022607 | cellular component assembly | 4 | 11 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 11 |
GO:0043933 | protein-containing complex organization | 4 | 11 |
GO:0065003 | protein-containing complex assembly | 5 | 11 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0006413 | translational initiation | 3 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003743 | translation initiation factor activity | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008135 | translation factor activity, RNA binding | 3 | 12 |
GO:0045182 | translation regulator activity | 1 | 12 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 29 | 33 | PF00656 | 0.421 |
CLV_C14_Caspase3-7 | 354 | 358 | PF00656 | 0.462 |
CLV_NRD_NRD_1 | 181 | 183 | PF00675 | 0.376 |
CLV_NRD_NRD_1 | 238 | 240 | PF00675 | 0.440 |
CLV_NRD_NRD_1 | 307 | 309 | PF00675 | 0.293 |
CLV_NRD_NRD_1 | 94 | 96 | PF00675 | 0.304 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.387 |
CLV_PCSK_KEX2_1 | 307 | 309 | PF00082 | 0.292 |
CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.224 |
CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.304 |
CLV_PCSK_PC1ET2_1 | 328 | 330 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 109 | 113 | PF00082 | 0.244 |
CLV_PCSK_SKI1_1 | 308 | 312 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 329 | 333 | PF00082 | 0.222 |
CLV_PCSK_SKI1_1 | 69 | 73 | PF00082 | 0.275 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.390 |
DEG_SPOP_SBC_1 | 195 | 199 | PF00917 | 0.415 |
DOC_PP4_FxxP_1 | 192 | 195 | PF00568 | 0.522 |
DOC_USP7_MATH_1 | 45 | 49 | PF00917 | 0.523 |
DOC_USP7_UBL2_3 | 371 | 375 | PF12436 | 0.416 |
LIG_14-3-3_CanoR_1 | 94 | 100 | PF00244 | 0.495 |
LIG_Actin_WH2_2 | 238 | 253 | PF00022 | 0.305 |
LIG_APCC_ABBA_1 | 7 | 12 | PF00400 | 0.429 |
LIG_BRCT_BRCA1_1 | 100 | 104 | PF00533 | 0.478 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.429 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.439 |
LIG_FHA_1 | 283 | 289 | PF00498 | 0.428 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.467 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.429 |
LIG_FHA_1 | 387 | 393 | PF00498 | 0.563 |
LIG_FHA_2 | 49 | 55 | PF00498 | 0.370 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.429 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.429 |
LIG_LIR_Apic_2 | 189 | 195 | PF02991 | 0.517 |
LIG_LIR_Apic_2 | 279 | 283 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 146 | 156 | PF02991 | 0.456 |
LIG_LIR_Gen_1 | 262 | 271 | PF02991 | 0.444 |
LIG_LIR_Gen_1 | 333 | 342 | PF02991 | 0.504 |
LIG_LIR_Gen_1 | 394 | 404 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 146 | 151 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 155 | 161 | PF02991 | 0.121 |
LIG_LIR_Nem_3 | 262 | 267 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 333 | 338 | PF02991 | 0.504 |
LIG_LIR_Nem_3 | 394 | 400 | PF02991 | 0.536 |
LIG_LYPXL_SIV_4 | 131 | 139 | PF13949 | 0.419 |
LIG_PCNA_PIPBox_1 | 65 | 74 | PF02747 | 0.478 |
LIG_PCNA_yPIPBox_3 | 59 | 72 | PF02747 | 0.480 |
LIG_PTB_Apo_2 | 114 | 121 | PF02174 | 0.523 |
LIG_PTB_Phospho_1 | 114 | 120 | PF10480 | 0.523 |
LIG_REV1ctd_RIR_1 | 212 | 220 | PF16727 | 0.321 |
LIG_SH2_CRK | 148 | 152 | PF00017 | 0.475 |
LIG_SH2_CRK | 335 | 339 | PF00017 | 0.504 |
LIG_SH2_GRB2like | 148 | 151 | PF00017 | 0.419 |
LIG_SH2_GRB2like | 264 | 267 | PF00017 | 0.467 |
LIG_SH2_SRC | 148 | 151 | PF00017 | 0.419 |
LIG_SH2_SRC | 278 | 281 | PF00017 | 0.358 |
LIG_SH2_STAP1 | 221 | 225 | PF00017 | 0.309 |
LIG_SH2_STAP1 | 264 | 268 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 319 | 323 | PF00017 | 0.494 |
LIG_SH2_STAT3 | 221 | 224 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.338 |
LIG_SH2_STAT5 | 227 | 230 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 249 | 252 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 346 | 349 | PF00017 | 0.442 |
LIG_SH3_3 | 207 | 213 | PF00018 | 0.312 |
LIG_SH3_3 | 339 | 345 | PF00018 | 0.412 |
LIG_SUMO_SIM_anti_2 | 297 | 305 | PF11976 | 0.429 |
LIG_TRAF2_1 | 186 | 189 | PF00917 | 0.505 |
LIG_TYR_ITIM | 395 | 400 | PF00017 | 0.509 |
LIG_UBA3_1 | 7 | 13 | PF00899 | 0.443 |
MOD_CK1_1 | 337 | 343 | PF00069 | 0.454 |
MOD_CK1_1 | 391 | 397 | PF00069 | 0.554 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.464 |
MOD_CK2_1 | 266 | 272 | PF00069 | 0.421 |
MOD_CK2_1 | 375 | 381 | PF00069 | 0.442 |
MOD_CK2_1 | 48 | 54 | PF00069 | 0.512 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.452 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.442 |
MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.422 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.329 |
MOD_GlcNHglycan | 268 | 271 | PF01048 | 0.345 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.311 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.369 |
MOD_GSK3_1 | 278 | 285 | PF00069 | 0.315 |
MOD_GSK3_1 | 330 | 337 | PF00069 | 0.499 |
MOD_N-GLC_1 | 184 | 189 | PF02516 | 0.470 |
MOD_N-GLC_1 | 195 | 200 | PF02516 | 0.430 |
MOD_NEK2_1 | 219 | 224 | PF00069 | 0.393 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.415 |
MOD_NEK2_1 | 330 | 335 | PF00069 | 0.458 |
MOD_NEK2_1 | 351 | 356 | PF00069 | 0.442 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.497 |
MOD_NEK2_2 | 45 | 50 | PF00069 | 0.504 |
MOD_PIKK_1 | 282 | 288 | PF00454 | 0.286 |
MOD_PIKK_1 | 93 | 99 | PF00454 | 0.504 |
MOD_PK_1 | 375 | 381 | PF00069 | 0.429 |
MOD_PKA_2 | 262 | 268 | PF00069 | 0.347 |
MOD_PKA_2 | 93 | 99 | PF00069 | 0.494 |
MOD_Plk_1 | 195 | 201 | PF00069 | 0.458 |
MOD_Plk_1 | 234 | 240 | PF00069 | 0.479 |
MOD_Plk_1 | 77 | 83 | PF00069 | 0.444 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.367 |
MOD_Plk_4 | 286 | 292 | PF00069 | 0.528 |
MOD_Plk_4 | 337 | 343 | PF00069 | 0.457 |
MOD_Plk_4 | 391 | 397 | PF00069 | 0.445 |
MOD_Plk_4 | 399 | 405 | PF00069 | 0.427 |
MOD_SUMO_for_1 | 49 | 52 | PF00179 | 0.504 |
MOD_SUMO_rev_2 | 101 | 111 | PF00179 | 0.442 |
TRG_DiLeu_BaEn_4 | 178 | 184 | PF01217 | 0.389 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 227 | 230 | PF00928 | 0.415 |
TRG_ENDOCYTIC_2 | 264 | 267 | PF00928 | 0.467 |
TRG_ENDOCYTIC_2 | 335 | 338 | PF00928 | 0.482 |
TRG_ENDOCYTIC_2 | 397 | 400 | PF00928 | 0.509 |
TRG_ER_diArg_1 | 180 | 182 | PF00400 | 0.370 |
TRG_ER_diArg_1 | 200 | 203 | PF00400 | 0.414 |
TRG_ER_diArg_1 | 261 | 264 | PF00400 | 0.481 |
TRG_ER_diArg_1 | 306 | 308 | PF00400 | 0.493 |
TRG_Pf-PMV_PEXEL_1 | 308 | 312 | PF00026 | 0.326 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4R0 | Leptomonas seymouri | 85% | 100% |
A0A0S4J145 | Bodo saltans | 35% | 100% |
A0A1X0NQN6 | Trypanosomatidae | 56% | 100% |
A0A3Q8IGX0 | Leishmania donovani | 100% | 100% |
A0A3R7MGF4 | Trypanosoma rangeli | 55% | 100% |
A1CKN7 | Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107) | 30% | 90% |
A1D6T6 | Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / CBS 544.65 / FGSC A1164 / JCM 1740 / NRRL 181 / WB 181) | 31% | 89% |
A4HGT5 | Leishmania braziliensis | 95% | 100% |
A4R796 | Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) | 29% | 91% |
A5AAA4 | Aspergillus niger (strain CBS 513.88 / FGSC A1513) | 31% | 90% |
A6SM77 | Botryotinia fuckeliana (strain B05.10) | 28% | 90% |
A7F3L0 | Sclerotinia sclerotiorum (strain ATCC 18683 / 1980 / Ss-1) | 30% | 90% |
A7RWP6 | Nematostella vectensis | 28% | 90% |
A8NY27 | Brugia malayi | 25% | 92% |
A8XFH3 | Caenorhabditis briggsae | 30% | 100% |
A9UQS1 | Monosiga brevicollis | 29% | 84% |
B0WAM5 | Culex quinquefasciatus | 28% | 93% |
B0XXL3 | Neosartorya fumigata (strain CEA10 / CBS 144.89 / FGSC A1163) | 30% | 90% |
B4MYA1 | Drosophila willistoni | 30% | 93% |
B4N3B0 | Drosophila willistoni | 31% | 93% |
B5DGH9 | Salmo salar | 28% | 91% |
D0A930 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 98% |
E9B052 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
O61820 | Caenorhabditis elegans | 26% | 94% |
O94513 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 32% | 81% |
P0CN50 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 28% | 87% |
P0CN51 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 28% | 87% |
P60228 | Homo sapiens | 28% | 91% |
P60229 | Mus musculus | 28% | 91% |
Q05AY2 | Xenopus laevis | 29% | 91% |
Q0CNR3 | Aspergillus terreus (strain NIH 2624 / FGSC A1156) | 31% | 91% |
Q0U0X1 | Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) | 29% | 93% |
Q1E170 | Coccidioides immitis (strain RS) | 30% | 91% |
Q1HQY6 | Aedes aegypti | 28% | 93% |
Q1LUA8 | Danio rerio | 28% | 91% |
Q2F5R8 | Bombyx mori | 29% | 91% |
Q2HBQ2 | Chaetomium globosum (strain ATCC 6205 / CBS 148.51 / DSM 1962 / NBRC 6347 / NRRL 1970) | 28% | 91% |
Q2UKS9 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 30% | 90% |
Q3B8M3 | Xenopus laevis | 29% | 91% |
Q3T102 | Bos taurus | 28% | 91% |
Q4PHN4 | Ustilago maydis (strain 521 / FGSC 9021) | 28% | 75% |
Q4Q833 | Leishmania major | 99% | 100% |
Q4R6G8 | Macaca fascicularis | 28% | 91% |
Q4WY08 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 30% | 90% |
Q54CC5 | Dictyostelium discoideum | 30% | 77% |
Q5B973 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 31% | 90% |
Q5R8K9 | Pongo abelii | 28% | 91% |
Q5ZLA5 | Gallus gallus | 28% | 91% |
Q641X8 | Rattus norvegicus | 28% | 91% |
Q6C0Q2 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 28% | 96% |
Q6DRI1 | Danio rerio | 29% | 91% |
Q6P7L9 | Xenopus tropicalis | 29% | 91% |
Q7QIL8 | Anopheles gambiae | 32% | 94% |
Q7S519 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 28% | 91% |
Q9C5Z3 | Arabidopsis thaliana | 30% | 92% |
V5BEE1 | Trypanosoma cruzi | 57% | 100% |